The role of low-molecular-weight heparin in recurrent implantation failure: a prospective, quasi-randomized, controlled study

BERKER B., TAŞKIN S., Kahraman K., Taskin E. A., Atabekoglu C., SÖNMEZER M.

FERTILITY AND STERILITY, cilt.95, sa.8, ss.2499-2502, 2011 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Editöre Mektup
  • Cilt numarası: 95 Sayı: 8
  • Basım Tarihi: 2011
  • Doi Numarası: 10.1016/j.fertnstert.2010.12.033
  • Dergi Adı: FERTILITY AND STERILITY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.2499-2502
  • Anahtar Kelimeler: Recurrent implantation failure, low molecular weight heparin, pregnancy outcome, implantation, EPIDERMAL-GROWTH-FACTOR, VITRO TROPHOBLAST INVASIVENESS, CELLS IN-VITRO, HUMAN BLASTOCYST, E-CADHERIN, BINDING, EGF, EXPRESSION, PREGNANCY, SURVIVAL
  • Ankara Üniversitesi Adresli: Evet

Özet

Low-molecular-weight heparin did not provide any beneficial effect on pregnancy outcomes in patients with two or more implantation failures. Further trials are needed to confirm a trend in favor of low-molecular-weight heparin in the subgroup with women with three or more implantation failures. (Fertil Steril (R) 2011; 95: 2499-502. (c) 2011 by American Society for Reproductive Medicine.)